Cargando…

The Role of IL-33 in Host Response to Candida albicans

Background. Interleukin (IL) 33 is a recently identified pleiotropic cytokine that influences the activity of multiple cell types and orchestrates complex innate and adaptive immune responses. Methods. We performed an extensive review of the literature published between 2005 and 2013 on IL-33 and re...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez-Cerdeira, C., Lopez-Bárcenas, A., Sánchez-Blanco, B., Arenas, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130336/
https://www.ncbi.nlm.nih.gov/pubmed/25136658
http://dx.doi.org/10.1155/2014/340690
_version_ 1782330317116276736
author Rodríguez-Cerdeira, C.
Lopez-Bárcenas, A.
Sánchez-Blanco, B.
Arenas, R.
author_facet Rodríguez-Cerdeira, C.
Lopez-Bárcenas, A.
Sánchez-Blanco, B.
Arenas, R.
author_sort Rodríguez-Cerdeira, C.
collection PubMed
description Background. Interleukin (IL) 33 is a recently identified pleiotropic cytokine that influences the activity of multiple cell types and orchestrates complex innate and adaptive immune responses. Methods. We performed an extensive review of the literature published between 2005 and 2013 on IL-33 and related cytokines, their functions, and their regulation of the immune system following Candida albicans colonization. Our literature review included cross-references from retrieved articles and specific data from our own studies. Results. IL-33 (IL-1F11) is a recently identified member of the IL-1 family of cytokines. Accumulating evidence suggests a pivotal role of the IL-33/ST2 axis in host immune defense against fungal pathogens, including C. albicans. IL-33 induces a Th2-type inflammatory response and activates both innate and adaptive immunity. Studies in animal models have shown that Th2 inflammatory responses have a beneficial role in immunity against gastrointestinal and systemic infections by Candida spp. Conclusions. This review summarizes the most important clinical studies and case reports describing the beneficial role of IL-33 in immunity and host defense mechanisms against pathogenic fungi. The finding that the IL-33/ST2 axis is involved in therapeutic target has implications for the prevention and treatment of inflammatory diseases, including acute or chronic candidiasis.
format Online
Article
Text
id pubmed-4130336
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-41303362014-08-18 The Role of IL-33 in Host Response to Candida albicans Rodríguez-Cerdeira, C. Lopez-Bárcenas, A. Sánchez-Blanco, B. Arenas, R. ScientificWorldJournal Review Article Background. Interleukin (IL) 33 is a recently identified pleiotropic cytokine that influences the activity of multiple cell types and orchestrates complex innate and adaptive immune responses. Methods. We performed an extensive review of the literature published between 2005 and 2013 on IL-33 and related cytokines, their functions, and their regulation of the immune system following Candida albicans colonization. Our literature review included cross-references from retrieved articles and specific data from our own studies. Results. IL-33 (IL-1F11) is a recently identified member of the IL-1 family of cytokines. Accumulating evidence suggests a pivotal role of the IL-33/ST2 axis in host immune defense against fungal pathogens, including C. albicans. IL-33 induces a Th2-type inflammatory response and activates both innate and adaptive immunity. Studies in animal models have shown that Th2 inflammatory responses have a beneficial role in immunity against gastrointestinal and systemic infections by Candida spp. Conclusions. This review summarizes the most important clinical studies and case reports describing the beneficial role of IL-33 in immunity and host defense mechanisms against pathogenic fungi. The finding that the IL-33/ST2 axis is involved in therapeutic target has implications for the prevention and treatment of inflammatory diseases, including acute or chronic candidiasis. Hindawi Publishing Corporation 2014 2014-07-21 /pmc/articles/PMC4130336/ /pubmed/25136658 http://dx.doi.org/10.1155/2014/340690 Text en Copyright © 2014 C. Rodríguez-Cerdeira et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Rodríguez-Cerdeira, C.
Lopez-Bárcenas, A.
Sánchez-Blanco, B.
Arenas, R.
The Role of IL-33 in Host Response to Candida albicans
title The Role of IL-33 in Host Response to Candida albicans
title_full The Role of IL-33 in Host Response to Candida albicans
title_fullStr The Role of IL-33 in Host Response to Candida albicans
title_full_unstemmed The Role of IL-33 in Host Response to Candida albicans
title_short The Role of IL-33 in Host Response to Candida albicans
title_sort role of il-33 in host response to candida albicans
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130336/
https://www.ncbi.nlm.nih.gov/pubmed/25136658
http://dx.doi.org/10.1155/2014/340690
work_keys_str_mv AT rodriguezcerdeirac theroleofil33inhostresponsetocandidaalbicans
AT lopezbarcenasa theroleofil33inhostresponsetocandidaalbicans
AT sanchezblancob theroleofil33inhostresponsetocandidaalbicans
AT arenasr theroleofil33inhostresponsetocandidaalbicans
AT rodriguezcerdeirac roleofil33inhostresponsetocandidaalbicans
AT lopezbarcenasa roleofil33inhostresponsetocandidaalbicans
AT sanchezblancob roleofil33inhostresponsetocandidaalbicans
AT arenasr roleofil33inhostresponsetocandidaalbicans